格段にうまくいくEVTの基本とコツ　第3版

出版社： 羊土社
著者：
発行日： 2023-08-15
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784758113014
電子書籍版： 2023-08-15 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

9,900 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

9,900 円(税込)

購入する

目次

  • 第１章　下肢動脈
    A　基本
    １．下肢動脈の血管造影
    ２．下肢閉塞性動脈疾患に対する血管内治療の適応
    ３．バイパス術の適応
    ４．ガイドワイヤーの種類と選択
    ５．デバイスの種類と選択
    ６．血管内イメージング
    ７．穿刺法
    ８．治療エンドポイントの決め方
    ９．下肢閉塞性動脈硬化症（PAD）の薬物療法
    10．術後フォロー
    B　単純病変
    １．腸骨動脈
    ２．浅大腿動脈
    ３．膝下動脈
    ４．トラブルシューティング
    C　複雑病変
    １．腸骨動脈
    １）高度石灰化を伴う大動脈分岐部
    ２）Leriche症候群に対する血管内治療
    ３）外腸骨から総大腿動脈閉塞
    ４）Trans-radial EVT
    ２．浅大腿動脈
    １）高度石灰化
    ２）長区域閉塞（体表エコーガイド）
    ３）長区域閉塞（IVUSガイド）
    ４）長区域閉塞（逆行性アプローチ）
    ５）長区域閉塞（Knuckle wire法）
    ６）ステント内再狭窄・再閉塞
    ３．膝下動脈
    １）高度石灰化
    ２）長区域閉塞（逆行性アプローチ）
    ３）Below the ankleインターベンション
    ４）No option CLTI
    ４．総大腿動脈
    ５．腹部大動脈狭窄
    ６．急性下肢動脈閉塞（ALI）
    D　画像診断の活用
    １．CT
    ２．体表エコー
    ３．IVUS
    ４．OFDI
    ５．血管内視鏡

    第２章　腎動脈・上腸間膜動脈・腹腔動脈
    １．血管造影
    ２．血管内治療の適応
    ３．血管内治療の実際（症例）
    《Topic》腎デナベーション療法

    第３章　鎖骨下動脈
    １．鎖骨下動脈の血管造影
    ２．血管内治療の適応
    ３．血管内治療の実際（症例）

    第４章　頸動脈
    １．頸動脈のカテーテル検査
    ２．血管内治療の適応
    ３．血管内治療の実際（症例）

    第５章　下肢静脈
    １．急性肺塞栓症・深部静脈血栓症：カテーテル治療
    ２．下肢静脈瘤
    ３．深部静脈疾患
    ４．下大静脈フィルター

    第６章　透析シャント
    １．末梢血管
    ２．中心静脈

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 下肢動脈

P.37 掲載の参考文献
1) Norgren L, et al:Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg, 45 Suppl S:S5-67, 2007
 
2) Conte MS, et al:Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg, 58:S1-S109.e33, 2019
 
3) Aboyans V, et al:2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS):Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by:the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 39:763-816, 2018
 
4) Rocha-Singh KJ, et al:Peripheral arterial calcification:prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv, 83:E212-E220, 2014
PubMed
5) Fujihara M, et al:Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease. J Endovasc Ther, 24:367-375, 2017
 
6) Kawarada O, et al:Awareness of anatomical variations for infrapopliteral intervention. Catheter Cardiovasc Interv, 76:888-894, 2010
PubMed
7) Hayakawa N, et al:Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease. Heart Vessels, 34:1740-1747, 2019
PubMed
8) Fujihara M, et al:Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease:a prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv, 85:870-877, 2015
PubMed
9) Utsunomiya M, et al:Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg, 55:113-121, 2012
PubMed
P.42 掲載の参考文献
1) Patel MR, et al:Evaluation and treatment of patients with lower extremity peripheral artery disease:consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol, 65:931-941, 2015
 
2) Fujihara M, et al:Clinical outcomes of endovascular procedure using VIABAHN(R) VBX covered stent in complex aortoiliac artery disease:Result from AVOCADO study. Catheter Cardiovasc Interv, 98:928-937, 2021
 
3) Aboyans V, et al:2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS):Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by:the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 39:763-816, 2018
 
4) Iida O, et al:Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg, 44:425-431, 2012
PubMed
5) Klein AJ, et al:SCAI appropriate use criteria for peripheral arterial interventions:An update. Catheter Cardiovasc Interv, 90:E90-E110, 2017
PubMed
6) Nakama T, et al:1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions:CAULIFLOWER Study Results. JACC Cardiovasc Interv, 15:1453-1463, 2022
PubMed
7) Goueffic Y, et al:Stenting or Surgery for De Novo Common Femoral Artery Stenosis. JACC Cardiovasc Interv, 10:1344-1354, 2017
 
8) Shishehbor MH, et al:Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts. J Vasc Surg, 70:1177-1191. e9, 2019
 
9) Gray WA, et al:A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL):a randomised, non-inferiority trial. Lancet, 392:1541-1551, 2018
 
10) Ohki T, et al:Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions. J Vasc Surg, 66:130-142. e1, 2017
 
11) Nakao S, et al:Incidence of Acute Thrombotic Occlusion and Its Predictors After Contemporary Femoropopliteal Endovascular Therapy in Patients With Peripheral Artery Disease. J Endovasc Ther:15266028221120519, 2022
PubMed
12) Overhagen HV, et al:SAVAL Primary Results of the Randomized Trial of DES vs PTA in Infrapopliteal Arteries. CIRSE 2022
 
13) Toyoshima T, et al:Effects of Infra-malleolar Status According to Global Limb Anatomic Staging System on Clinical Outcomes in Patients With Chronic Limb-Threatening Ischemia. Angiology:33197221091642, 2022
PubMed
P.46 掲載の参考文献
1) Conte MS:Critical appraisal of surgical revascularization for critical limb ischemia. J Vasc Surg, 57:8S-13S, 2013
PubMed
2) Iida O, et al:Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia:The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia). Circ Cardiovasc Interv, 10:e005531, 2017
PubMed
3) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
4) Conte MS, et al:Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities:management of asymptomatic disease and claudication. J Vasc Surg, 61:2S-41S, 2015
PubMed
5) Klinkert P, et al:Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting:five-year results of a randomized controlled trial. J Vasc Surg, 37:149-155, 2003
PubMed
6) Aboyans V, et al:Editor's Choice-2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg, 55:305-368, 2018
 
7) Iida O, et al:Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg, 44:425-431, 2012
PubMed
8) Farber A, et al:Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med, 387:2305-2316, 2022
 
9) Conte MS, et al:Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, 69:3S-125S. e40, 2019
 
10) Azuma N, et al:Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia. Circ Cardiovasc Interv, 12:e008015, 2019
PubMed
11) Kikuchi S, et al:Effectiveness and Safety of Ultrasound Guided Lower Extremity Nerve Blockade in Infragenicular Bypass Grafting for High Risk Patients With Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg, 58:206-213, 2019
PubMed
P.68 掲載の参考文献
1) Dotter CT & Judkins MP:Transluminal Treatment of Arteriosclerotic Obstruction Description of a New Technic and a Preliminary Report of Its Application. Circulation, 30:654-670, 1964
 
2) Gruntzig A & Hopff H:Perkutane Rekanalisation chronischer arterieller Verschlusse mit einem neuen Dilatationskatheter. Dtsch Med Wochenschr, 99:2502-10, 2511, 1974
PubMed
3) Tobis JM, et al:Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation, 83:913-926, 1991
PubMed
4) Kozuki A, et al:Outcomes of Dissection Angles as Predictor of Restenosis after Drug-Coated Balloon Treatment. J Atheroscler Thromb, 28:954-962, 2021
PubMed
5) Nakamura S, et al:Intracoronary ultrasound observations during stent implantation. Circulation, 89:2026-2034, 1994
PubMed
6) Tsubakimoto Y, et al:IVUS-Guided Wiring Improves the Clinical Outcomes of Angioplasty for Long Femoropopliteal CTO Compared with the Conventional Intraluminal Approach. J Atheroscler Thromb, 28:365-374, 2021
PubMed
7) Divakaran S, et al:Temporal Trends, Practice Variation, and Associated Outcomes With IVUS Use During Peripheral Arterial Intervention. JACC Cardiovasc Interv, 15:2080-2090, 2022
PubMed
P.78 掲載の参考文献
1) Yamauchi Y, et al:One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions. Circ Cardiovasc Interv, 12:e007441, 2019
PubMed
2) Yamauchi Y, et al:Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions. Circ Cardiovasc Interv, 13:e009168, 2020
PubMed
3) Utsunomiya M, et al:Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg, 55:113-121, 2012
PubMed
4) Shishehbor MH, et al:Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. N Engl J Med, 388:1171-1180, 2023
PubMed
P.83 掲載の参考文献
1) Antithrombotic Trialists' Collaboration:Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 324:71-86, 2002
PubMed
2) Regensteiner JG, et al:Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease:meta-analysis of six randomized controlled trials. J Am Geriatr Soc, 50:1939-1946, 2002
PubMed
3) Mohler ER 3rd, et al:Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue:a double-blinded, randomized, controlled trial. J Am Coll Cardiol, 41:1679-1686, 2003
PubMed
4) Norgren L, et al:Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European study. Vasc Med, 11:75-83, 2006
PubMed
5) Mohler ER 3rd, et al:Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation, 108:1481-1486, 2003
PubMed
6) Berger JS, et al:Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease:a meta-analysis of randomized trials. JAMA, 301:1909-1919, 2009
PubMed
7) CAPRIE Steering Committee:A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 348:1329-1339, 1996
 
8) Berger PB, et al:Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease:results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation, 121:2575-2583, 2010
 
9) Hiatt WR, et al:Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. N Engl J Med, 376:32-40, 2017
PubMed
10) Douglas JS Jr, et al:Coronary stent restenosis in patients treated with cilostazol. Circulation, 112:2826-2832, 2005
PubMed
11) Iida O, et al:Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation, 127:2307-2315, 2013
PubMed
12) Yokoyama M:[Japan EPA Lipid Intervention Study (JELIS). Randomized clinical trial involving primary and secondary prevention of cardiovascular events with EPA in hypercholesterolemia]. Nihon Ronen Igakkai Zasshi, 46:22-25, 2009
PubMed
13) Eikelboom JW, et al:Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med, 377:1319-1330, 2017
 
14) Bonaca MP, et al:Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med, 382:1994-2004, 2020
PubMed
15) Heart Protection Study Collaborative Group:MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals:a randomised placebo-controlled trial. Lancet, 360:7-22, 2002
 
16) Mach F, et al:2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk. Eur Heart J, 41:111-188, 2020
PubMed
17) 日本動脈硬化学会:動脈硬化性疾患予防ガイドライン2022年版. 日本動脈硬化学会, 2022
 
18) Yusuf S, et al:Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. N Engl J Med, 342:145-153, 2000
PubMed
19) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2019. ライフサイエンス出版, 2019
 
20) Dormandy JA, et al:Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):a randomised controlled trial. Lancet, 366:1279-1289, 2005
PubMed
21) Marso SP, et al:Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med, 375:311-322, 2016
PubMed
22) Zinman B, et al:Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med, 373:2117-2128, 2015
PubMed
23) Ueki K, et al:Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3):an open-label, randomised controlled trial. Lancet Diabetes Endocrinol, 5:951-964, 2017
PubMed
P.86 掲載の参考文献
1) Iida O, et al:Retrospective multicentre analysis of S.M.A.R.T. vs. Luminexx Nitinol stent implantation for superficial femoral artery lesions(REAL SL)registry? 5years' experience ? Circ J, 75:421-427, 2011
 
2) Iida O, et al:Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg, 44:425-431, 2012
PubMed
3) Miyashita Y, et al:Cilostazol increases skin perfusion pressure in severey ischemic limbs. Angiology, 62:15-17, 2011
 
P.104 掲載の参考文献
1) Soga Y, et al:Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J, 76:2697-2704, 2012
PubMed
2) Yamauchi Y, et al:Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions. Circ Cardiovasc Interv, 13:e009168, 2020
PubMed
3) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
4) 山内靖隆:Iliac CTO病変に対する体表面エコーガイドワイヤリング. 「超音波ガイドEVT 体表面エコー, IVUSの徹底活用で手技成功に導く」(平野敬典/編), pp183-191, メジカルビュー社, 2020
 
5) Feldman DN, et al:SCAI guidelines on device selection in Aorto-Iliac arterial interventions. Catheter Cardiovasc Interv, 96:915-929, 2020
PubMed
6) de Cort BA, et al:Long-Term Outcome for Covered Endovascular Reconstruction of Aortic Bifurcation for Aortoiliac Disease:A Single-Center Experience. J Endovasc Ther, 28:906-913, 2021
PubMed
7) Yamauchi Y, et al:Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation. Heart Vessels, 35:614-619, 2020
PubMed
P.114 掲載の参考文献
1) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
2) Biondi-Zoccai GG, et al:Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia:learning curve, complications, and technical tips and tricks. Catheter Cardiovasc Interv, 68:835-842, 2006
PubMed
P.128 掲載の参考文献
1) Kawarada O, et al:Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy. J Endovasc Ther:15266028221134886, 2022
PubMed
2) Kawarada O, et al:Contemporary critical limb ischemia:Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care. Cardiovasc Interv Ther, 33:297-312, 2018
 
3) Kawarada O, et al:Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv, 80:861-871, 2012
PubMed
4) Kawarada O, et al:Awareness of anatomical variations for infrapopliteral intervention. Catheter Cardiovasc Interv, 76:888-894, 2010
PubMed
5) Taylor GI & Palmer JH:The vascular territories (angiosomes) of the body:experimental study and clinical applications. Br J Plast Surg, 40:113-141, 1987
PubMed
6) Kawarada O, et al:Effect of single tibial artery revascularization on microcirculation in the setting of critical limb ischemia. Circ Cardiovasc Interv, 7:684-691, 2014
PubMed
7) Kawarada O:Clinical utility of 3 French infrapopliteal intervention in the setting of critical limb ischemia. J Invasive Cardiol, 21:383-385, 2009
PubMed
8) Kawarada O, et al:Contemporary crossing techniques for infrapopliteal chronic total occlusions. J Endovasc Ther, 21:266-280, 2014
PubMed
9) Kawarada O, et al:Longitudinal Cracking with a Guidewire Tail for Extremely Calcified Lesions in Infrainguinal Arteries:PICKING Technique. Cardiovasc Intervent Radiol, 41:313-316, 2018
PubMed
10) Kawarada O, et al:Stent-assisted below-the-ankle angioplasty for limb salvage. J Endovasc Ther, 18:32-42, 2011
PubMed
11) Kawarada O, et al:Impact of end-stage renal disease in patients with critical limb ischaemia undergoing infrapopliteal intervention. EuroIntervention, 10:753-760, 2014
PubMed
12) Yagyu T, et al:Rationale and Design of a Prospective, Multicenter, Single-Arm Clinical Trial to Investigate the Safety and Effectiveness of Rotablator Atherectomy System as an Adjunctive Device for Endovascular Treatment of Occlusive Atherosclerotic Lesions in Below-the-Knee Arteries With Critical Limb Ischemia (RESCUE-BTK). Circ Rep, 2:449-454, 2020
PubMed
P.142 掲載の参考文献
1) Aspelin P, et al:Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med, 348:491-499, 2003
PubMed
P.147 掲載の参考文献
1) Feldman DN, et al:SCAI guidelines on device selection in Aorto-Iliac arterial interventions. Catheter Cardiovasc Interv, 96:915-929, 2020
PubMed
2) Grimme FA, et al:Editor's Choice--First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease. Eur J Vasc Endovasc Surg, 50:638-647, 2015
 
3) Soga Y, et al:Treatment for aortoiliac bifurcation disease by balloon-expandable covered stent;"Double-D" molding technique. J Cardiol Cases, 22:143-146, 2020
 
P.150 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会:2020年改訂版 大動脈瘤・大動脈解離診療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf
 
2) Anderson JL, et al:Clinical practice guidelines on perioperative cardiovascular evaluation:collaborative efforts among the ACC, AHA, and ESC. Circulation, 130:2213-2214, 2014
PubMed
3) Grimme FA, et al:Editor's Choice--First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease. Eur J Vasc Endovasc Surg, 50:638-647, 2015
 
4) Soga Y, et al:Treatment for aortoiliac bifurcation disease by balloon-expandable covered stent;"Double-D" molding technique. J Cardiol Cases, 22:143-146, 2020
 
P.161 掲載の参考文献
1) Gargiulo G, et al:Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention:Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. Circulation, 146:1329-1343, 2022
 
2) Shinozaki N, et al:Initial results of transradial iliac artery stenting. Vasc Endovascular Surg, 48:51-54, 2014
PubMed
3) Shinozaki N, et al:Slender transradial iliac artery stenting using a 4.5 French guiding sheath. Cardiovasc Interv Ther, 34:9-13, 2019
PubMed
4) Meertens MM, et al:Transradial Approach for Aortoiliac and Femoropopliteal Interventions:A Systematic Review and Meta-analysis. J Endovasc Ther, 25:599-607, 2018
 
5) Shinozaki N & Ikari Y:Distal radial artery approach for endovascular therapy. Cardiovasc Interv Ther, 37:533-537, 2022
PubMed
6) Shinozaki N & Ikari Y:Superficial femoral artery stenting via radial access using R2P(R) Misago(R) stents:First-inhuman report of the new R2P(R) system. SAGE Open Med Case Rep, 7:2050313X19847348, 2019
 
P.170 掲載の参考文献
1) Fitzgerald PJ, et al:Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation, 86:64-70, 1992
PubMed
2) Maleckis K, et al:Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. J Mech Behav Biomed Mater, 75:160-168, 2017
PubMed
3) Scheinert D, et al:Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol, 45:312-315, 2005
PubMed
4) Zeller T, et al:Helical Centerline Stent Improves Patency:Two-Year Results From the Randomized Mimics Trial. Circ Cardiovasc Interv, 9:e002930, 2016
PubMed
5) Iida O, et al:1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery):Predictors of Restenosis. JACC Cardiovasc Interv, 8:1105-1112, 2015
PubMed
6) Tzafriri AR, et al:Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis. J Control Release, 264:203-210, 2017
PubMed
7) Fanelli F, et al:Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol, 37:898-907, 2014
PubMed
8) Soga Y, et al:Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. J Am Heart Assoc, 12:e025677, 2023
PubMed
9) Garcia LA, et al:SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent. Catheter Cardiovasc Interv, 89:1259-1267, 2017
PubMed
10) Nakama T, et al:Angioscopic Findings on 15-Month Follow-Up for Interwoven Nitinol Stent Invagination in the Femoropopliteal Artery. JACC Cardiovasc Interv, 13:1958-1959, 2020
PubMed
11) Iida O, et al:One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study. J Endovasc Ther, 28:123-131, 2021
PubMed
12) Kurata N, et al:Factors Influencing in-Stent Occlusion after Femoropopliteal Artery Stent Placement with Intravascular Ultrasound Evaluation. J Vasc Interv Radiol, 31:213-220, 2020
PubMed
13) Dias-Neto M, et al:Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Paveand-Crack" Technique:Technical Description and 12-Month Results. J Endovasc Ther, 25:334-342, 2018
PubMed
14) Iida O, et al:Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions:The J-SUPREME and J-SUPREME II Trials. J Endovasc Ther, 29:240-247, 2022
 
P.184 掲載の参考文献
1) Kawasaki D, et al:Novel use of ultrasound guidance for recanalization of iliac, femoral, and popliteal arteries. Catheter Cardiovasc Interv, 71:727-733, 2008
PubMed
2) Hayakawa N, et al:Efficacy of navigating through the intraplaque route using AnteOwl WR intravascular ultrasound in femoropopliteal chronic total occlusion. CVIR Endovasc, 4:37, 2021
PubMed
3) Hayakawa N, et al:An AnteOwl WR intravascular ultrasound-guided parallel wiring technique for chronic total occlusion of below-the-knee arteries. CVIR Endovasc, 5:18, 2022
PubMed
4) Okamura A, et al:Tip Detection Method Using the New IVUS Facilitates the 3-Dimensional Wiring Technique for CTO Intervention. JACC Cardiovasc Interv, 13:74-82, 2020
PubMed
P.193 掲載の参考文献
1) Schmidt A, et al:Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions. J Endovasc Ther, 19:23-29, 2012
 
2) Urasawa K, et al:Trans-collateral angioplasty for the treatment of long chronic total occlusions of superficial femoral arteries:a novel wiring technique. J Cardiovasc Surg (Torino), 55:395-400, 2014
PubMed
3) Tan M, et al:Anterolateral Popliteal Puncture Technique:A Novel Retrograde Approach for Chronic Femoropopliteal Occlusions. J Endovasc Ther, 24:525-530, 2017
PubMed
P.206 掲載の参考文献
1) Schillinger M, et al:Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 354:1879-1888, 2006
PubMed
2) Lee JM, et al:Differential Prognostic Effect Between First-and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions:Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. JACC Cardiovasc Interv, 8:1318-1331, 2015
PubMed
3) Tan M, et al:Three-Year Clinical Outcomes Following Implantation of LifeStent Self-Expanding Nitinol Stents in Patients With Femoropopliteal Artery Lesions. Angiology, 73:244-251, 2022
PubMed
4) Gray WA, et al:A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL):a randomised, non-inferiority trial. Lancet, 392:1541-1551, 2018
 
5) Iida O, et al:1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice:Predictors of Restenosis and Aneurysmal Degeneration. JACC Cardiovasc Interv, 15:630-638, 2022
PubMed
6) Tosaka A, et al:Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol, 59:16-23, 2012
PubMed
7) Anantha-Narayanan M, et al:Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease:An updated meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv, 94:139-148, 2019
PubMed
8) Feldman DN, et al:SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv, 92:124-140, 2018
PubMed
9) Tomoi Y, et al:Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting. Heart Vessels, 36:646-653, 2021
PubMed
10) Bosiers M, et al:Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery:24-month results from a multicenter randomized trial. J Cardiovasc Surg (Torino), 61:617-625, 2020
 
11) Dippel EJ, et al:Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis:initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv, 8:92-101, 2015
PubMed
12) Gandini R, et al:Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia:a single-center, prospective, randomized study. J Endovasc Ther, 20:805-814, 2013
PubMed
13) Kokkinidis DG, et al:Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis:2-Year outcomes. Catheter Cardiovasc Interv, 95:439-446, 2020
PubMed
14) Kuntz SH, et al:Pathology and Multimodality Imaging of Acute and Chronic Femoral Stenting in Humans. JACC Cardiovasc Interv, 13:418-427, 2020
PubMed
P.210 掲載の参考文献
1) Ichihashi S, et al:Technique of percutaneous direct needle puncture of calcified plaque in the superficial femoral artery or tibial artery to facilitate balloon catheter passage and balloon dilation of calcified lesions. J Vasc Interv Radiol, 25:784-788, 2014
PubMed
2) Kum S, et al:The direct extravascular calcium interruption arterial procedure technique for heavily calcified vessels. J Vasc Surg Cases Innov Tech, 6:369-373, 2020
 
3) Kawarada O, et al:Longitudinal Cracking with a Guidewire Tail for Extremely Calcified Lesions in Infrainguinal Arteries:PICKING Technique. Cardiovasc Intervent Radiol, 41:313-316, 2018
PubMed
4) Nakama T, et al:Efficacy of the novel inner PIERCE technique for severely calcified below-the-knee occlusions in a patient with chronic limb-threatening ischemia. Catheter Cardiovasc Interv, 96:1317-1322, 2020
 
5) Takei T, et al:A novel technique of percutaneous intraluminal cracking using a puncture needle for severe calcified lesions of below-the-knee and below-the-ankle arteries. Diagn Interv Radiol, 27:413-417, 2021
PubMed
P.224 掲載の参考文献
1) Nakama T, et al:Clinical Outcomes of Pedal Artery Angioplasty for Patients With Ischemic Wounds:Results From the Multicenter RENDEZVOUS Registry. JACC Cardiovasc Interv, 10:79-90, 2017
PubMed
2) Huizing E, et al:Below-the-Ankle Angioplasty in Patients with Critical Limb Ischemia:A Systematic Review and Meta-Analysis. J Vasc Interv Radiol, 30:1361-1368. e2, 2019
 
3) Tsubakimoto Y, et al:Outcomes of Pedal Artery Angioplasty Are Independent of the Severity of Inframalleolar Disease:A Subanalysis of the Multicenter RENDEZVOUS Registry. J Endovasc Ther, 27:186-193, 2020
PubMed
4) Conte MS, et al:Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, 69:3S-125S.e40, 2019
 
P.229 掲載の参考文献
1) Tan M, et al:Prediction of successful guidewire crossing of below-the-knee chronic total occlusions using a Japanese scoring system. J Vasc Surg, 74:506-513.e2, 2021
 
2) Nakama T, et al:Clinical Implications of Additional Pedal Artery Angioplasty in Critical Limb Ischemia Patients With Infrapopliteal and Pedal Artery Disease. J Endovasc Ther, 23:83-91, 2016
 
3) Nakama T, et al:Clinical Outcomes of Pedal Artery Angioplasty for Patients With Ischemic Wounds:Results From the Multicenter RENDEZVOUS Registry. JACC Cardiovasc Interv, 10:79-90, 2017
PubMed
4) Huizing E, et al:Below-the-Ankle Angioplasty in Patients with Critical Limb Ischemia:A Systematic Review and Meta-Analysis. J Vasc Interv Radiol, 30:1361-1368.e2, 2019
 
5) Metser G, et al:Clinical Outcomes of Additional Below-The-Ankle Intervention Compared to Below-The-Knee Intervention Alone:A Post-Hoc Analysis of a Prospective Multicenter Study. J Endovasc Ther:15266028221092981, 2022
 
6) Kum S, et al:Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia. J Endovasc Ther, 24:619-626, 2017
PubMed
7) Schmidt A, et al:Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia:The ALPS Multicenter Study. J Endovasc Ther, 27:658-665, 2020
PubMed
8) Shishehbor MH, et al:Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. N Engl J Med, 388:1171-1180, 2023
PubMed
9) Ichihashi S, et al:Simplified Endovascular Deep Venous Arterialization for Non-option CLI Patients by Percutaneous Direct Needle Puncture of Tibial Artery and Vein Under Ultrasound Guidance (AV Spear Technique). Cardiovasc Intervent Radiol, 43:339-343, 2020
PubMed
10) Nakama T, et al:Angiographic Findings of the Development of a Reverse Blood Supply After Percutaneous Deep Venous Arterialization. JACC Cardiovasc Interv, 13:1489-1491, 2020
PubMed
11) Nakama T, et al:Twelve-Month Clinical Outcomes of Percutaneous Deep Venous Arterialization with Alternative Techniques and Ordinary Endovascular Therapy Devices for Patients with Chronic Limb-Threatening Ischemia:Results of the DEPARTURE Japan Study. Cardiovasc Intervent Radiol, 45:622-632, 2022
PubMed
12) Ysa A, et al:Homemade Device to Facilitate Percutaneous Venous Arterialization in Patients With No-Option Critical Limb Ischemia. J Endovasc Ther, 26:213-218, 2019
PubMed
P.233 掲載の参考文献
1) Kuma S, et al:Clinical Outcome of Surgical Endarterectomy for Common Femoral Artery Occlusive Disease. Circ J, 80:964-969, 2016
PubMed
2) Nakama T, et al:1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions:CAULIFLOWER Study Results. JACC Cardiovasc Interv, 15:1453-1463, 2022
PubMed
3) Iwata Y, et al:Crossover stenting across the deep femoral artery entry:a multicenter retrospective study. Cardiovasc Interv Ther, 33:372-378, 2018
PubMed
4) Goueffic Y, et al:Stenting or Surgery for De Novo Common Femoral Artery Stenosis. JACC Cardiovasc Interv, 10:1344-1354, 2017
 
P.237 掲載の参考文献
1) Inahara T:Evaluation of endarterectomy for aortoiliac and aortoiliofemoral occlusive disease. Arch Surg, 110:1458-1464, 1975
PubMed
2) Brewster DC:Clinical and anatomical considerations for surgery in aortoiliac disease and results of surgical treatment. Circulation, 83:I42-I52, 1991
PubMed
3) Huber TS, et al:Operative mortality rates after elective infrarenal aortic reconstructions. J Vasc Surg, 22:287-93;discussion 293, 1995
 
4) Mwipatayi BP, et al:A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg, 54:1561-1570, 2011
 
5) Bruijnen RC, et al:Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease. J Vasc Surg, 55:674-678, 2012
 
6) Feugier P, et al:Endovascular treatment of isolated atherosclerotic stenosis of the infrarenal abdominal aorta:long-term outcome. Ann Vasc Surg, 17:375-385, 2003
PubMed
7) Tatiana B, et al:Aortic Stenting in Symptomatic Infrarenal Aortic Stenosis and Subtotal Aortic Occlusion. Vasc Endovascular Surg, 53:303-309, 2019
PubMed
8) Monastiriotis S, et al:Clinical characteristics and outcome of isolated infrarenal aortic stenosis in young patients. J Vasc Surg, 67:1143-1149, 2018
PubMed
9) Onder H, et al:Endovascular treatment of surgically implanted arterial graft thrombosis by using manual aspiration thrombectomy. Diagn Interv Radiol, 19:340-344, 2013
 
10) Ohshiro T, et al:Sexual function in patients with aortoiliac vascular disorders. Int Surg, 67:49-52, 1982
PubMed
11) Odurny A, et al:Percutaneous transluminal angioplasty of abdominal aortic stenoses. Cardiovasc Intervent Radiol, 12:1-6, 1989
PubMed
12) Poncyljusz W, et al:Primary stenting in the treatment of focal atherosclerotic abdominal aortic stenoses. Clin Radiol, 61:691-695, 2006
PubMed
13) Berczi A, et al:Early and long-term results of the endovascular treatment of patients with isolated infrarenal aortic stenosis. J Vasc Surg, 73:510-515.e2, 2021
 
P.252 掲載の参考文献
1) 日本血管外科学会データベース管理運営委員会, 他:血管外科手術アニュアルレポート2017年. 日血管外会誌, 30:359-379,2021
 
2) 日本血管外科学会データベース管理運営委員会, 他:血管外科手術アニュアルレポート2011年. 日血管外会誌, :45-64,2017
Medical*Online
3) de Donato G, et al:The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia. J Vasc Surg, 59:729-736, 2014
PubMed
4) Higashitani M, et al:One-year limb outcome and mortality in patients undergoing revascularization therapy for acute limb ischemia:short-term results of the Edo registry. Cardiovasc Interv Ther, 36:226-236, 2021
PubMed
5) Dormandy J, et al:Acute limb ischemia. Semin Vasc Surg, 12:148-153, 1999
PubMed
6) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
7) Gong M, et al:Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis:Efficacy and Safety Compared to Urokinase. Clin Appl Thromb Hemost, 24:1333-1339, 2018
PubMed
8) Olinic DM, et al:Acute Limb Ischemia:An Update on Diagnosis and Management. J Clin Med, 8:1215, 2019
PubMed
P.268 掲載の参考文献
1) Mori S, et al:Feasibility of Ultrasound-Guided Transoccluded Radial Access for Coronary Angiography or Percutaneous Coronary Intervention. JACC Cardiovasc Interv, 13:2088-2090, 2020
PubMed
2) Tokuda T, et al:Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease. Catheter Cardiovasc Interv, 97:E518-E524, 2021
PubMed
3) Mori S, et al:Usefulness of ultrasound-guided intraluminal approach for long occlusive femoropopliteal lesion. Heart Vessels, 36:376-382, 2021
PubMed
4) Tokuda T, et al:Feasibility and impact of extra-vascular ultrasound-guided endovascular treatment for infrapopliteal artery occlusive disease. Catheter Cardiovasc Interv, 101:870-876, 2023
PubMed
5) 平野敬典:体表面エコーガイドワイヤリングの考え方とワイヤーの動かし方の基礎. 「超音波ガイドEVT 体表面エコー, IVUSの徹底活用で手技成功に導く」(平野敬典/編), pp31-53, メジカルビュー社, 2020
 
P.275 掲載の参考文献
1) Fujihara M, et al:Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther, 37:597-612, 2022
PubMed
P.285 掲載の参考文献
1) Fujihara M, et al:Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther, 37:597-612, 2022
PubMed
2) Tsujimura T, et al:Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention. Circ J, 84:1999-2005, 2020
PubMed
3) Nishino M, et al:Novel Endovascular Therapy, AGET, for In-Stent Occlusions in Iliac and Femoropopliteal Arteries. Int Heart J, 63:874-880, 2022
PubMed

第2章 腎動脈・上腸間膜動脈・腹腔動脈

P.291 掲載の参考文献
1) Aboyans V, et al:2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS):Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by:the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 39:763-816, 2018
 
2) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
3) Hirsch AT, et al:ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic):a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease):endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation;National Heart, Lung, and Blood Institute;Society for Vascular Nursing;TransAtlantic Inter-Society Consensus;and Vascular Disease Foundation. Circulation, 113:e463-e654, 2006
 
4) Safian RD & Textor SC:Renal-artery stenosis. N Engl J Med, 344:431-442, 2001
PubMed
5) Weber BR & Dieter RS:Renal artery stenosis:epidemiology and treatment. Int J Nephrol Renovasc Dis, 7:169-181, 2014
PubMed
6) Cooper CJ, et al:Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med, 370:13-22, 2014
PubMed
7) The ASTRAL Investigators:Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med, 361:1953-1962, 2009
PubMed
8) Bax L, et al:Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function:a randomized trial. Ann Intern Med, 150:840-848, W150, 2009
 
9) Zeller T, et al:A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR)-one-year results of a pre-maturely terminated study. Trials, 18:380, 2017
 
10) Gornik HL, et al:First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med, 24:164-189, 2019
PubMed
11) Cudnik MT, et al:The diagnosis of acute mesenteric ischemia:A systematic review and meta-analysis. Acad Emerg Med, 20:1087-1100, 2013
PubMed
12) Lehtimaki TT, et al:Detecting acute mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion:Review of 95 consecutive patients. Eur J Radiol, 84:2444-2453, 2015
PubMed
13) Akyildiz H, et al:The correlation of the D-dimer test and biphasic computed tomography with mesenteric computed tomography angiography in the diagnosis of acute mesenteric ischemia. Am J Surg, 197:429-433, 2009
 
14) Beaulieu RJ, et al:Comparison of open and endovascular treatment of acute mesenteric ischemia. J Vasc Surg, 59:159-164, 2014
PubMed
15) Block TA, et al:Endovascular and open surgery for acute occlusion of the superior mesenteric artery. J Vasc Surg, 52:959-966, 2010
PubMed
16) Arthurs ZM, et al:A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg, 53:698-704;discussion 704, 2011
 
17) Schermerhorn ML, et al:Mesenteric revascularization:management and outcomes in the United States, 1988-2006. J Vasc Surg, 50:341-348. e1, 2009
 
18) Bjorck M, et al:Revascularization of the superior mesenteric artery after acute thromboembolic occlusion. Br J Surg, 89:923-927, 2002
PubMed
19) Moneta GL, et al:Mesenteric duplex scanning:a blinded prospective study. J Vasc Surg, 17:79-84;discussion 85, 1993
 
20) Oliva IB, et al:ACR Appropriateness Criteria(R) imaging of mesenteric ischemia. Abdom Imaging, 38:714-719, 2013
 
P.308 掲載の参考文献
1) Kandzari DE, et al:Catheter-based renal denervation for resistant hypertension:rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol, 35:528-535, 2012
PubMed
2) Bhatt DL, et al:A controlled trial of renal denervation for resistant hypertension. N Engl J Med, 370:1393-1401, 2014
PubMed
3) Sakakura K, et al:Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol, 64:635-643, 2014
 
4) Mahfoud F, et al:Catheter-based renal denervation is no simple matter:lessons to be learned from our anatomy? J Am Coll Cardiol, 64:644-646, 2014
PubMed
5) Kandzari DE, et al:Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J, 36:219-227, 2015
PubMed
6) Mountfort K, et al:Catheter-based Renal Sympathetic Denervation-Long-term Symplicity(TM) Renal Denervation Clinical Evidence, New Data and Future Perspectives. Interv Cardiol, 8:118-123, 2013
 
7) Townsend RR, et al:Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED):a randomised, sham-controlled, proofof-concept trial. Lancet, 390:2160-2170, 2017
 
8) Mauri L, et al:A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation:The RADIANCE-HTN and REQUIRE clinical study designs. Am Heart J, 195:115-129, 2018
PubMed
9) Mabin T, et al:First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention, 8:57-61, 2012
PubMed
10) Pathak A, et al:Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity. EuroIntervention, 11:477-484, 2015
PubMed
11) Mahfoud F & Bohm M:Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. Int J Cardiol, 249:365, 2017
 
12) Stiermaier T, et al:Endovascular ultrasound for renal sympathetic denervation in patients with therapy-resistant hypertension not responding to radiofrequency renal sympathetic denervation. EuroIntervention, 12:e282-e289, 2016
 
13) Kario K, et al:Catheter-based ultrasound renal denervation in patients with resistant hypertension:the randomized, controlled REQUIRE trial. Hypertens Res, 45:221-231, 2022
PubMed
14) Azizi M, et al:Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO):a randomised, multicentre, single-blind, sham-controlled trial. Lancet, 397:2476-2486, 2021
PubMed
15) Azizi M, et al:Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO):a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet, 391:2335-2345, 2018
 
16) Azizi M, et al:Endovascular Ultrasound Renal Denervation to Treat Hypertension:The RADIANCE II Randomized Clinical Trial. JAMA, 329:651-661, 2023
PubMed

第3章 鎖骨下動脈

P.313 掲載の参考文献
1) Soga Y, et al:Perioperative and Long-term Outcomes of Endovascular Treatment for Subclavian Artery Disease From a Large Multicenter Registry. J Endovasc Ther, 22:626-633, 2015
PubMed
2) 日本循環器学会/日本血管外科学会:2022年改訂版 末梢動脈疾患ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf
 
P.319 掲載の参考文献
1) Soga Y, et al:Perioperative and Long-term Outcomes of Endovascular Treatment for Subclavian Artery Disease From a Large Multicenter Registry. J Endovasc Ther, 22:626-633, 2015
PubMed
2) Soga Y, et al:Brachiocephalic and Subclavian Artery Aneurysm Treated With Covered Stent. JACC Case Rep, 4:719-720, 2022
PubMed

第4章 頸動脈

P.327 掲載の参考文献
1) 日本脳卒中学会:「関連11学会承認 頚動脈ステント留置術実施基準」改訂のお知らせ 2012.4.1. 2012 http://jsnet.website/4annai2/401-12-01CASkijun.html
 

第5章 下肢静脈

P.342 掲載の参考文献
1) 日本循環器学会:肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン(2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf
 
P.352 掲載の参考文献
1) 日本静脈学会ホームページ(https://js-phlebology.jp/)
 
P.372 掲載の参考文献
1) Masuda E, et al:The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. J Vasc Surg Venous Lymphat Disord, 8:505-525. e4, 2020
 
2) 孟 真, 他:「下肢静脈瘤に対する血管内焼灼術のガイドライン2019」不適切治療症例に関する追補. 静脈学, 31:39-43, 2020
 
3) Lurie F, et al:The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord, 8:342-352, 2020
PubMed
4) Vasquez MA, et al:Revision of the venous clinical severity score:venous outcomes consensus statement:special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg, 52:1387-1396, 2010
 
5) 星野祐二:評価スケール. 「慢性深部静脈不全の評価と治療」(星野祐二/著), pp39-46, 日本医事新報社, 2023
 
6) Masuda E, et al:The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. J Vasc Surg Venous Lymphat Disord, 8:505-525. e4, 2020
 
7) De Maeseneer MG, et al:Editor's Choice-European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg, 63:184-267, 2022
 
P.389 掲載の参考文献
1) Milovanovic L, et al:Procedural and indwelling complications with inferior vena cava filters:frequency, etiology, and management. Semin Intervent Radiol, 32:34-41, 2015
PubMed
2) Mismetti P, et al:Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism:a randomized clinical trial. JAMA, 313:1627-1635, 2015
PubMed
3) Ohyama Y, et al:Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan-JROAD and JROAD-DPC Registry Analysis. Circ Rep, 1:296-302, 2019
PubMed
4) Tao MJ, et al:Temporary inferior vena cava filter indications, retrieval rates, and follow-up management at a multicenter tertiary care institution. J Vasc Surg, 64:430-437, 2016
 
5) Ahmed O, et al:Rising Retrieval Rates of Inferior Vena Cava Filters in the United States:Insights From the 2012 to 2016 Summary Medicare Claims Data. J Am Coll Radiol, 15:1553-1557, 2018
 
6) 日本循環器学会:肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン(2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf
 
7) Wang SL & Singer MA:Toward an optimal position for inferior vena cava filters:computational modeling of the impact of renal vein inflow with Celect and TrapEase filters. J Vasc Interv Radiol, 21:367-74;quiz 374, 2010
 
8) Morales JP, et al:Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord, 1:376-384, 2013
PubMed
9) Anzai H, et al:Impact of Advanced Technique on Improvement in the Retrievable Inferior Vena Cava Filter Retrieval Rate. Circ J, 85:377-384, 2021
PubMed
10) Kaufman JA, et al:Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease:Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol, 31:1529-1544, 2020
 
11) Lee C, et al:Routine Removal of Inferior Vena Cava Filters. N Engl J Med, 386:2149-2151, 2022
PubMed
12) Iliescu B & Haskal ZJ:Advanced techniques for removal of retrievable inferior vena cava filters. Cardiovasc Intervent Radiol, 35:741-750, 2012
PubMed
13) Al-Hakim R, et al:The hangman technique:a modified loop snare technique for the retrieval of inferior vena cava filters with embedded hooks. J Vasc Interv Radiol, 26:107-110, 2015
 
14) Kuo WT, et al:Laser-Assisted Removal of Embedded Vena Cava Filters:A First-In-Human Escalation Trial in 500 Patients Refractory to High-Force Retrieval. J Am Heart Assoc, 9:e017916, 2020
PubMed
15) Anzai H, et al:Bidirectional Sling Technique with Biopsy Forceps for Inferior Vena Cava Filter Retrieval. Ann Vasc Dis, 14:277-280, 2021
PubMed

第6章 透析シャント

P.399 掲載の参考文献
1) 厚生労働省:第7回NDBオープンデータ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177221_00011.html
 
2) Lookstein RA, et al:Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med, 383:733-742, 2020
PubMed
3) Mohr BA, et al:Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial. J Vasc Interv Radiol, 30:203-211. e4, 2019
 
P.414 掲載の参考文献
1) 日本透析医学会:慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 日本透析医学会雑誌, 38:1491-1551, 2005
 
2) 日本透析医学会:2011年版 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌, 44:855-937, 2011
 
3) 堀田祐紀, 他:透析シャント肢の中心静脈病変(鎖骨下静脈・腕頭静脈・腸骨静脈)に対するPTAの成績. 腎と透析, 72:160-163, 2012
 
4) Horita Y:Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients. J Vasc Access, 20:87-92, 2019
 
5) 堀田祐紀, 他:中心静脈狭窄症および閉塞症. 臨牀透析, 38:969-980, 2022
 
6) Surratt RS, et al:The importance of preoperative evaluation of the subclavian vein in dialysis access planning. AJR Am J Roentgenol, 156:623-625, 1991
PubMed
7) Glanz S, et al:Axillary and subclavian vein stenosis:percutaneous angioplasty. Radiology, 168:371-373, 1988
PubMed
8) Oe K, et al:Impact of inflow reduction of arteriovenous fistula on systemic hemodynamics in a patient with high-output heart failure during hemodialysis:A case report. J Cardiol Cases, 1:e98-e101, 2010
 
9) Horita Y, et al:Serial cardiac influence of volume overload induced by interventional therapy for central venous stenosis or occlusion in chronic hemodialysis patients. J Cardiol, 57:316-324, 2011
PubMed
10) Kaneko K, et al:Complete atrioventricular block due to venous stent migration from innominate vein to right ventricle:a case report. J Cardiol, 53:453-457, 2009
PubMed
11) Nael K, et al:Endovascular management of central thoracic veno-occlusive diseases in hemodialysis patients:a single institutional experience in 69 consecutive patients. J Vasc Interv Radiol, 20:46-51, 2009
PubMed
12) Horita Y, et al:Initial and long-term outcomes of Percutaneous Transluminal Angioplasty for central venous stenosis or occlusion in chronic hemodialysis patients:Analysis of 363 lesions in single center.Arch Clin Nephrol, 7:9-17, 2021
 
13) Lookstein RA, et al:Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med, 383:733-742, 2020
PubMed
14) 堀田祐紀:短期間に繰り返す透析シャント再狭窄に対する薬剤溶出性バルーン(drug-coated balloon)の臨床効果. 日本透析医学会雑誌, 50:81-86,2017
 

第7章 腹部大動脈瘤

P.424 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会:2020年改訂版 大動脈瘤・大動脈解離診療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf
 
2) 日本ステントグラフト実施基準管理委員会:腹部大動脈瘤ステントグラフト 実施基準. http://stentgraft.jp/pro/aaa/
 
3) Chaikof EL, et al:The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg, 67:2-77. e2, 2018
 

書評

最近チェックした商品履歴

Loading...